5PSQ-068 Incidence of fungal infections in patients treated with ixekizumab

Background and importanceIL-17 mediated immunity is essential for the protection of skin and mucous membranes against fungal infections. Candida infections have been reported in pivotal trials of antibody agents against IL-17, such as ixekizumab. However, there is little evidence in real world patie...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2020-03, Vol.27 (Suppl 1), p.A181-A181
Hauptverfasser:	Báez, N, Rodríguez Ramallo, H, Gallego Muñoz, C, Mejias Trueba, M, Soriano Martínez, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Arthritis Diabetes Fungal infections Monoclonal antibodies Psoriasis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!